Source: Virtual Congress 2021 – Immunological and molecular characterisation of tuberculosis disease and infection



Rating:

Share or cite this content

Citations should be made in the following way:
G. Shepelkova (Moscow, Russian Federation), V. Evstifeev (Moscow, Russian Federation), I. Sivokozov (Moscow, Russian Federation), T. Azhikina (Moscow, Russian Federation), A. Ergeshov (Moscow, Russian Federation), V. Yeremeev (Moscow, Russian Federation). Mycobacterial small noncoding RNAs MTS0997 and MTS1338 are novel virulence factors of M. tuberculosis.. 2465

Member's Comments

No comment yet.

Related content which might interest you: Whole genome sequencing of Mycobacterium tuberculosis Source: Eur Respir J, 52 (5) 1801163; 10.1183/13993003.01163-2018 Year: 2018 Mycobacterium tuberculosis borderline rpoB mutations: emerging from the unknown Source: Eur Respir J, 58 (3) 2100783; 10.1183/13993003.00783-2021 Year: 2021 Risk factors for recent transmission of Mycobacterium tuberculosis Source: Eur Respir J 2003 Oct 01;22(4):637-642 Year: 2003 Identification of species of tuberculous and nontuberculous mycobacteria based on the hsp-65 gene polymorphism Source: Annual Congress 2004 - Genetics and immunology of tuberculosis Year: 2004 A set of microRNA markers of active tuberculosis. Source: Virtual Congress 2020 – Diagnostic challenges in tuberculosis Year: 2020 A proteomics approach for the identification of species-specific immunogenic proteins in the Mycobacterium abscessus complex Source: International Congress 2019 – Infection and inflammation in cystic fibrosis Year: 2019 Exosomal miRNAs and association with pulmonary tuberculosis Source: International Congress 2019 – Mechanisms underlying respiratory infection Year: 2019 Can M. smegmatis be used as a real alternative for M. tuberculosis? Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR Year: 2016 Design of immunogenic multiepitopic mycobacterium tuberculosis peptides from genes selected using in vitro models of mycobacterial macrophage infection Source: Eur Respir J 2007; 30: Suppl. 51, 493s Year: 2007 Cloning of 38Kd DNA sequence from M.tuberculosis Source: Annual Congress 2003 - Genetics and immunobiology of tuberculosis Year: 2003 Molecular analysis of mutations in genes associated with multidrug-resistance in Mycobacterium tuberculosis isolates from patients with tuberculosis in Moscow region, Russia Source: International Congress 2018 – Drug-resistant tuberculosis Year: 2018 Accelerated analysis of reactivation of the dormant Mycobacterium tuberculosis using mycobacteriophage D29. Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases Year: 2021 23S rRNA mutations in linezolid-resistant clinical isolates of M. tuberculosis: A report of two cases Source: Annual Congress 2013 –Diagnostic features of tuberculosis II Year: 2013 Characterization of drug susceptibility of nontuberculous mycobacteria of M.chelonae and M.fortuitum complexes. Source: International Congress 2018 – Challenges in treating tuberculosis and nontuberculous mycobacteria Year: 2018 In silico analysis of tuberculosis and multiple sclerosis gene expression profiles reveals coregulated genes implicated in host response to pathogens. Source: International Congress 2017 – Human susceptibility to tuberculosis Year: 2017 Study of genetic heterogeneity in Mycobacterium tuberculosis isolates from tuberculosis patients using DNA fingerprinting Source: Eur Respir J 2005; 26: Suppl. 49, 655s Year: 2005 Diagnostic of sensitivity mycobacterium tuberculosis strains to isoniazid and rifampicin by simultaneous identification of mutations in rpoB, katG, inhA and ahpC-oxyR genes with biological microchips Source: Eur Respir J 2006; 28: Suppl. 50, 379s Year: 2006 Cap-independent translation of human SP-A 5‘-UTR variants; a double-loop structure and cis-element contribution Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009 Assessment of sputum Mycobacterium tuberculosis messenger RNA levels in anti-microbial treatment monitoring Source: Annual Congress 2005 - Management of tuberculosis pulmonary, extrapulmonary peculiarities Year: 2005